期刊文献+

MRI征象及ADC值鉴别成人颅内髓母细胞瘤与室管膜瘤的价值 被引量:1

Differentiating adult intracranial medulloblastoma and ependymoma using MRI signs and ADC
下载PDF
导出
摘要 目的:探索磁共振成像(MRI)征象及表观扩散系数(ADC)值在鉴别成人颅内髓母细胞瘤与室管膜瘤中的价值。方法:回顾性分析手术及病理证实的16例成人颅内髓母细胞瘤及24例室管膜瘤临床、MRI及病理资料,对比MRI征象及ADC值差异,使用受试者工作特征(ROC)曲线评估ADC值在两组肿瘤鉴别诊断中的效能。结果:成人髓母细胞瘤与室管膜瘤在年龄、肿瘤位置和强化程度比较差异有统计学意义(P<0.05),两组患者性别、形态、肿瘤边界、囊变、瘤周水肿、肿瘤最大径、水肿最大径等比较差异无统计学意义(P>0.05);成人室管膜瘤ADC_(mean)、ADC_(min)及rADC值均大于成人髓母细胞瘤,差异有统计学意义(P<0.05)。ADC_(mean)阈值为665.00 mm^(2)/s时,鉴别诊断成人髓母细胞瘤与室管膜瘤的性能最佳,AUC值为0.966,敏感度和特异度分别为0.958、0.937。结论:通过MRI征象联合ADC值对术前鉴别成人髓母细胞瘤与室管膜瘤具有重要的临床价值,有助于辅助临床术前制定个性化诊疗方案。 Objective To explore the value of MRI signs and apparent diffusion coefficient(ADC)in differentiating adult intracranial medulloblastoma from ependymoma.Methods The clinical,MRI and pathological data of 16 adults with intracranial medulloblastoma and 24 with ependymoma confirmed by surgery and pathology were retrospectively analyzed.The differences between two groups in MRI signs andADC values were compared,and receiver operating characteristic curve was used to assess the diagnostic efficacy ofADC values in the differentiation of adult intracranial medulloblastoma and ependymoma.Results There were statistically significant differences between adult medulloblastoma and ependymoma in age,tumor location and degree of enhancement(P<0.05),but not in gender,morphology,tumor boundary,cystic degeneration,peritumoral edema,maximum diameter of the tumor,and maximum diameter of edema(P>0.05).TheADC_(mean),ADC_(min) and rADC values of adult ependymoma were greater than those of adult medulloblastoma,and the differences were statistically significant(P<0.05).When the ADC_(mean) threshold was 665.00 mm^(2)/s,it had the best performance for the differential diagnosis of adult medulloblastoma and ependymoma,with anAUC of 0.966,and its sensitivity and specificity were 0.958 and 0.937,respectively.Conclusion The combination of MRI signs and ADC has important clinical value for the preoperative differentiation of adult medulloblastoma and ependymoma,and it is helpful to assist the formulation of preoperative personalized diagnosis and treatment scheme.
作者 薛彩强 李昇霖 刘显旺 邓娟 周俊林 XUE Caiqiang;LI Shenglin;LIU Xianwang;DENG Juan;ZHOU Junlin(Department of Radiology,Lanzhou University Second Hospital,Lanzhou 730030,China;The Second Clinical Medical School,Lanzhou University,Lanzhou 730030,China;Key Laboratory of Medical Imaging of Gansu Province,Lanzhou 730030,China;Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence,Lanzhou 730030,China)
出处 《中国医学物理学杂志》 CSCD 2022年第10期1244-1249,共6页 Chinese Journal of Medical Physics
基金 国家自然科学基金(82071872) 兰州大学中央高校基本科研业务费专项资金资助(lzujbky-2021-kb32)。
关键词 髓母细胞瘤 室管膜瘤 磁共振成像 表观扩散系数 medulloblastoma ependymoma magnetic resonance imaging apparent diffusion coefficient
  • 相关文献

参考文献11

二级参考文献69

  • 1张俊平,赛克,魏大年,牟永告,张湘衡,吴秋良,陈忠平.MGMT阳性恶性脑胶质瘤病人的化疗(附51例体会)[J].中华神经外科杂志,2007,23(9):672-674. 被引量:18
  • 2Giese A,Bjerkvig R,Berens ME,et al.Cost of migration:invasion of malignant gliomas and implications for treatment[J].J Clin Oncol,2003,21 (8):1624-1636.
  • 3Burger PC,Dubois PJ,Schold SC Jr,et al.Computerized tomographic and pathologic studies of the untreated,quiescent,and recurrent glioblastoma multiforme[J].J Neurosurg,1983,58 (2):159-169.
  • 4Nitta RT,Li G.The invasive nature of glioblastoma[J].World Neurosurg,2013,80 (3-4):279-280.
  • 5Yan H,Parsons DW,Jin G,et al.IDH1 and IDH2 mutations in gliomas[J].New Engl J Med,2009,360 (8):765-773.
  • 6Hegi ME,Diserens A,Godard S,et al.Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide[J].Clin Cancer Res,2004,10 (6):1871-1874.
  • 7Hegi ME,Diserens A,Gorlia T,et al.MGMT gene silencing and benefit from temozolomide in glioblastoma[J].New Engl J Med,2005,352(10):997-1003.
  • 8Chinot OL,Barrié M,Fuentes S,et al.Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide[J].J Clin Oncol,2007,25 (12):1470-1475.
  • 9Mellai M,Monzeglio O,Piazzi A,et al.MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors[J].J Neurooncol,2012,107 (3):617-631.
  • 10Carrillo JA,Lai A,Nghiemphu PL,et al.Relationship between tumor enhancement,edema,IDH1 mutational status,MGMT promoter methylation,and survival in glioblastoma[J].Am J Neuroradiol,2012,33 (7):1349-1355.

共引文献82

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部